Header cover image

Australian Pharmaceuticals & Biotech Established, Profitable and Undervalued

UPDATED Aug 12, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CSLCSLAU$292.85-1.3%-1.6%AU$141.1bAU$311.37PE43.1xE15.1%1.1%
Page 1 of 1